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Percutaneous dilatational tracheostomies have
become one of the most frequently performed
surgical procedures in the ICU, and are believed to
offer a variety of advantages over open tracheostomies,
including increased convenience. Recent publications
have established that the risk of fatal complications
related to the procedure is low. However, clinicians
must still weigh these risks against expected but
largely unproven benefits. More research is needed
to establish the indications for the procedure,
including the optimal patient selection and timing
during a course of mechanical ventilation. Such
studies should also seek to improve our ability to
accurately identify which patients will require
prolonged mechanical ventilation, and to quantify
the potential benefits of tracheostomy compared
with prolonged translaryngeal intubation.authors) to estimate the denominator for these publishedIn a previous issue of Critical Care, Simon and colleagues
provide a contribution that helps clarify the safety of
the percutaneous dilatational tracheostomy procedure [1].
Tracheostomy is one of the most common surgical
procedures performed in the ICU [2], and percutaneous
tracheostomies have now largely replaced the open trache-
ostomy technique [3,4]. The percutaneous approach allows
the procedure to be performed in the ICU instead of in
the operating room, making it more convenient to
arrange and avoiding competition for limited operating
room resources [5]. The percutaneous approach is also a
skill that can be taught to intensivists, whereas surgeons
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2014Most evaluations of percutaneous tracheostomies have
suggested that their safety profile is similar to that of the
open procedure in unselected ICU patients [5]. However,
there are several problems inherent to defining the safety
of new procedures. For example, safety information
derived from comparative randomised trials may fail to
detect safety concerns because of limited sample size
and restrictive inclusion and exclusion criteria. Adverse
events that occur in routine practice are seldom cap-
tured by the medical literature, introducing a potential
for publication and reporting bias [6]. Finally, the re-
quirements for post-market surveillance that have been
developed for pharmaceutical therapies seldom exist for
new surgical techniques.
Simon and colleagues systematically reviewed the
peer-reviewed literature spanning a 28-year period to
catalogue and describe the complications reported to be
associated with the procedure [1]. In addition, they went
to great lengths (including contacting all corresponding
reports, a necessary step for estimating the incidence of
associated complications. To corroborate these risk esti-
mates, they also augmented the literature review with a
thorough analysis of their own departmental records
representing real-world data and an accurate local esti-
mate of complications relative to total number of proce-
dures. They concluded that the incidence of lethal
complications is low: only 1.7 deaths per 1,000 proce-
dures. Furthermore, the greatest risk of fatality occurred
during the procedure (nearly one-third of deaths), sug-
gesting that there still may be opportunities to improve
the safety of the operative technique and reduce compli-
cations [7]. Finally, this study from Simon and colleagues
suggests several potential risk factors for encountering
complications, although their methodology precluded a
systematic evaluation of these factors.
Future research in this field should attempt to answer
a number of remaining research questions. We need to
identify the residual role for the open tracheostomy,ed Central Ltd. The licensee has exclusive rights to distribute this article, in any
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mon and are only being performed in the most technic-
ally challenging and highest risk patients. There is still a
need for further research to inform the indications for
all types of tracheostomy, including the optimal patient
selection and timing during an episode of mechanical
ventilation [8]. Although the risk of percutaneous trache-
ostomy may seem low, whether patients should be sub-
jected to this risk without clear benefits to the procedure
is debatable.
With the publication of the TracMan trial, we know that
there is no benefit of early (≤4 days) versus late (≥10 days)
tracheostomy [9]. Future studies should therefore focus
on the benefits and risks of avoiding tracheostomy in
favour of prolonged translaryngeal intubation, as well as
on the value of late versus later tracheostomies in general
ICU patients. We also need to improve our ability to
accurately identify which patients will require prolonged
mechanical ventilation both to aid clinical decision-making
and to improve study validity [9,10]. Finally, we believe
that some patient populations – for example, those with
chronic respiratory conditions or underlying neurological
injury – may have risk–benefit profiles that differ from
general ICU patients, and this should be further
explored.
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